Schroder European Recovery Z Acc
Why is this fund on our radar?
Schroder European Recovery provides a distinctive investment option for investors. The manager invests in European equities following a deep value strategy, looking for companies trading at the most depressed share price, and from the largest to smallest in the market. This translates to a very different set of exposures compared to the wider market and the typical similar fund. Investments typically come from sectors such as basic materials, energy, consumer cyclicals, industrials and financials, although the wide ranging mandate means that a stock from any sector could find a position in the portfolio with the right value and recovery opportunity. The fund’s long-term performance is impressive, scoring well for its performance as well as for protecting in more challenging markets. This notably has come at different times to more mainstream managers and as a result its correlation to the market is low compared to a typical fund in its sector. Consequently, it might make a ngood addition to a portfolio where other elements are more correlated.
Skip to Our VerdictPerformance
Over the last five years the fund’s returns have compounded at c. 15.2% a year compared to the average fund in the peer group of 9.6%, and the benchmark, 11.1%. As we discuss below, performance can come at different times compared to the market and the peer group of other European funds due to its deep value style. Although only a short time period, it is interesting that in 2025 year to date, when European equities have performed well at an index level, the fund’s contrarian style has resulted in strong outperformance. This is likely due to its greater weight in banks, which is a sector that international investors reallocating capital from the US have been drawn to. Equally, some of the largest companies in the region such as Novo Nordisk, have performed badly, and as a result many of the fund’s competitors have underperformed. Over this short period, the fund has risen c. 22%, the comparison benchmark by 16% and the peer group average by c. 14%. In contrast, over ten years the fund has lagged the peer group and benchmark, compounding at 7.3% a year compared to the benchmark and peer group’s returns of 9.3% and 8.5%, which is a reminder that a deep value strategy can lag in certain backdrops.
The chart below highlights how Schroder European Recovery’s performance can vary significantly from the average. It shows discrete calendar year performance against the IA Europe ex UK peer group of similar funds, as well as a European ETF. As it illustrates, the fund’s performance can be very different to the peer group and can often move in the opposite direction. This comes with the fund’s very distinctive deep value style, which could also be described as ‘contrarian’. Buying stocks that others are selling, or ignoring, can clearly result in times when the fund will underperform. But equally, when the wider market begins to recognise that a stock is recovering, Schroder European Recovery Fund might already be there to benefit from the resulting momentum.
Performance vs peer group
Source: Morningstar
Past performance is not a reliable indicator of future returns
Portfolio
Schroder European Recovery’s deep value approach leads to a very different mix of stocks and sectors to the index and peer group. More growth-orientated managers, which is the contrasting style that is more common in the peer group, tend to gravitate towards the index’s largest sectors of technology, healthcare and industrials (for which one can often read ‘industrial technology’), Schroder European Recovery’s portfolio is more biased to energy, basic materials, real estate and consumer stocks. While the fund is underweight financial services as a whole, its largest positions include several European banks, which are likely to be a factor in its strong recent performance, as this is a sector that has led the recent rally in European equities. One of the key factors that has helped shift investor sentiment to a more positive frame of mind is Germany’s planned infrastructure spending plans, and this is likely to benefit many of its holdings, from materials to engineering and to real estate. Further, with consumer confidence rising slowly, some of its cyclical positions in luxury goods, which growth managers have sold down in the last year, could see a recovery and confidence builds. Again, a more robust German economy showing signs of growth will likely be a very positive factor. Overall, the portfolio provides a contrast to other funds and the index, with less exposure to expensive defence stocks, technology and healthcare and greater exposure to cheaper sectors, often with lower exposure to international trade and thus to the evolving US trade tariff policy, that could perform very well as Europe’s outlook continues to improve.
Our Verdict
To be very clear, this is certainly not a lower risk or capital preservation fund. Deep value investing requires a certain degree of contrarianism and not all businesses that meet deep value criteria will make it out the other side to the recovery phase. Schroder European Recovery’s performance shows that plenty do though, and the manager clearly has the skill to distinguish ‘value’ from ‘value trap’. The last year or so has seen a significant rise in European markets, while at the same time some of the most highly owned stocks and sectors, for example healthcare giant Novo Nordisk, or global luxury goods champion LVMH, have not performed well at all and thus many active funds have struggled to keep up with the market. Perhaps not these examples specifically, but these types of stocks can and do find their way into the portfolio at much lower valuations, which just goes to show that the fund is not simply buying small obscure businesses on low valuations, but successful global businesses that may be experiencing a cyclical downturn, or require a change in company strategy. Sometimes, as investors in US equities have learned, the right thing to do is to follow the ‘crowded trade’ but other times, as we’ve seen this year in Europe, it can been better to go against the crows and Schroder European Recovery provides an excellent case study in how successful that approach can be.
Key Risks
- A deep value contrarian strategy is likely to perform very differently to the index
- The strategy invests across the market cap range and exposure to small and mid-sized companies can be more volatile and risky
- In benign market conditions that favour growth stocks, the strategy can lag the index